1Savaga H. Safety and efficacy of intriavitreal triamcinolone[J]. Arch Ophthalmol,2004,122(7) : 1083-1085.
2Macky TA, Helmy D, El Shazly N. Retinal toxicity of triamcinolone's vehicle (benzyl alcohol) an electrophysiologie and electron microscopic study [J]. Graefes Arch Clin Exp Ophthalmol, 2007,245(6) : 817-824.
3Ip MS, Gottlieb JI, Kahana A, et al. Intravitreal injection of corticosteroid for the treatment of macular edema asscociated with central retinal vein occlusion [J]. Arch Ophthalmol,2004, 122(8):1131-1136.
4Jonas JB, Sofker A. Intraoeular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema[J]. Am J Ophthalmol,2001,132(3):425-427.
5Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of trimncinolone acetonide after a single inravitreal injection[J]. Ophthalmology,2003,110(4) :681-686.
6Jonas JB. Concentration of inravitreally injected triamcinolone acetonide in aqueous humour [J]. Br J Ophthalmol,2002,86(9): 1066-1069.
7Mason JO, Somaiva MP, Singh RJ. Intravitreal concentration and clearance of triamcinolonc acetonide in nonvitrctomized human eyes[J]. Retina, 2004,24(6) :900-904.
8Michael R, Susan SL, Hyuncheol K, et al. A rabbit model for assessing the ocular barriers to the transscleral delivery of triameinolone acetonide[J]. Exp Eye Res,2006,82(3):479-487.
9Mizuno S, Nishiwaki A, Morita FL, et al. Effects of periocular administration of triamcinolone acetonide on leukocyte-endothelium interactions in the ischemic retina [J]. Invest Ophthalmol Vis Sci,2007,48(6):2831-2836.
10Moshfeghi AA, Scottl U, Flynn HW Jr, et al. Pseudohypopyon after inravitreal triamcinolone acetonid injection for cystoid macular edema[J]. Am J Ophthalmol,2004,138(3):489-492.
